Hiroki Shimoda

Lymphovascular invasion and nodal positivity may identify candidates for adjuvant nivolumab in high-risk muscle-invasive urothelial carcinoma

OBJECTIVE: To identify patients with high-risk muscle-invasive urothelial carcinoma (MIUC) who derive greater benefit from adjuvant nivolumab after radical surgery. PATIENTS AND METHODS: This single-center retrospective study included 246 patients with high-risk MIUC who underwen...